Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
Open Access Rheumatology : Research and Reviews
|
December 4, 2009
Bioboosters in the treatment of rheumatic diseases: a comprehensive review of currently available biologics in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
Fabrizio Cantini, Carlotta Nannini, Laura Niccoli
Current Opinion in Rheumatology
|
April 5, 2008
Lung disease in rheumatoid arthritis
Carlotta Nannini, Jay H Ryu, Eric L Matteson
International Journal of Rheumatic Diseases
|
February 14, 2012
Frequency of anemia of inflammation in patients with ankylosing spondylitis requiring anti-TNFα drugs and therapy-induced changes
Laura Niccoli, Carlotta Nannini, Emanuele Cassarà, et al.
European Journal of Rheumatology
|
January 9, 2018
Rapid loss of efficacy of biosimilar infliximab in three patients with Behçet's disease after switching from infliximab originator
Fabrizio Cantini, Laura Niccoli, Carlotta Nannini, et al.
Biologics : Targets & Therapy
|
January 16, 2013
Duration of remission after halving of the etanercept dose in patients with ankylosing spondylitis: a randomized, prospective, long-term, follow-up study
Fabrizio Cantini, Laura Niccoli, Emanuele Cassarà, et al.
The Journal of Rheumatology. Supplement
|
November 3, 2015
Uveitis in Spondyloarthritis: An Overview
Fabrizio Cantini, Carlotta Nannini, Emanuele Cassarà, et al.
Drugs & Aging
|
March 26, 2008
Diagnosis and treatment of giant cell arteritis
Fabrizio Cantini, Laura Niccoli, Carlotta Nannini, et al.
The Journal of Rheumatology. Supplement
|
July 4, 2012
Infliximab in psoriatic arthritis
Fabrizio Cantini, Laura Niccoli, Carlotta Nannini, et al.
Biologics : Targets & Therapy
|
August 21, 2012
Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study
Fabrizio Cantini, Laura Niccoli, Emanuele Cassarà, et al.
Arthritis Research & Therapy
|
October 22, 2008
Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies
Carlotta Nannini, Colin P West, Patricia J Erwin, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
Open Access Rheumatology : Research and Reviews
|
December 4, 2009
Bioboosters in the treatment of rheumatic diseases: a comprehensive review of currently available biologics in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
Fabrizio Cantini, Carlotta Nannini, Laura Niccoli
Current Opinion in Rheumatology
|
April 5, 2008
Lung disease in rheumatoid arthritis
Carlotta Nannini, Jay H Ryu, Eric L Matteson
International Journal of Rheumatic Diseases
|
February 14, 2012
Frequency of anemia of inflammation in patients with ankylosing spondylitis requiring anti-TNFα drugs and therapy-induced changes
Laura Niccoli, Carlotta Nannini, Emanuele Cassarà, et al.
European Journal of Rheumatology
|
January 9, 2018
Rapid loss of efficacy of biosimilar infliximab in three patients with Behçet's disease after switching from infliximab originator
Fabrizio Cantini, Laura Niccoli, Carlotta Nannini, et al.
Biologics : Targets & Therapy
|
January 16, 2013
Duration of remission after halving of the etanercept dose in patients with ankylosing spondylitis: a randomized, prospective, long-term, follow-up study
Fabrizio Cantini, Laura Niccoli, Emanuele Cassarà, et al.
The Journal of Rheumatology. Supplement
|
November 3, 2015
Uveitis in Spondyloarthritis: An Overview
Fabrizio Cantini, Carlotta Nannini, Emanuele Cassarà, et al.
Drugs & Aging
|
March 26, 2008
Diagnosis and treatment of giant cell arteritis
Fabrizio Cantini, Laura Niccoli, Carlotta Nannini, et al.
The Journal of Rheumatology. Supplement
|
July 4, 2012
Infliximab in psoriatic arthritis
Fabrizio Cantini, Laura Niccoli, Carlotta Nannini, et al.
Biologics : Targets & Therapy
|
August 21, 2012
Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study
Fabrizio Cantini, Laura Niccoli, Emanuele Cassarà, et al.
Arthritis Research & Therapy
|
October 22, 2008
Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies
Carlotta Nannini, Colin P West, Patricia J Erwin, et al.
Page
of 4